市場調査レポート
商品コード
1309716

ポイントオブケア分子診断の世界市場規模、シェア、産業動向分析レポート:製品・サービス別、エンドユーザー別、技術別、用途別、地域別展望と予測、2023年~2030年

Global Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service, By End User, By Technology, By Application, By Regional Outlook and Forecast, 2023 - 2030

出版日: | 発行: KBV Research | ページ情報: 英文 313 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
ポイントオブケア分子診断の世界市場規模、シェア、産業動向分析レポート:製品・サービス別、エンドユーザー別、技術別、用途別、地域別展望と予測、2023年~2030年
出版日: 2023年06月30日
発行: KBV Research
ページ情報: 英文 313 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ポイントオブケア分子診断市場規模は2030年までに41億米ドルに達し、予測期間中にCAGR 10.2%の市場成長率で上昇すると予測されます。

KBVカーディナルマトリックスに示された分析によると、F. Hoffmann-La Roche Ltd.が同市場における先駆者です。2020年6月、ロシュはSpeeDxと提携し、ロシュ・ダイアグノスティックスは性感染症患者の抗生物質耐性を検出するための重要かつ高度なツールを臨床医に提供できるようになっています。Danaher Corporation、Thermo Fisher Scientific, Inc.、Abbott Laboratoriesなどの企業は、この市場における主要なイノベーターです。

市場成長要因

高齢者の増加

実質的にどの国でも、人口に占める高齢者の割合は増加しています。WHOは、2030年までに世界の6人に1人が60歳以上になると推定しています。この時点で、60歳以上の人口は14億人となり、2020年の10億人から増加します。60歳以上の人口は、2050年までに21億人と倍増します。予測期間中、世界の高齢化により呼吸器疾患や障害の有病率が高まるため、POC(ポイント・オブ・ケア)分子診断薬に対する需要が増加します。

分散型ヘルスケアシステムの普及が市場拡大を支える

正確かつ効率的な治療選択に必要な迅速な診断結果のため、ポイントオブケア検査は患者中心のヘルスケアに不可欠となっています。慢性疾患、感染症、慢性疾患に対する集中型ポイントオブケア検査から分散型検査への変化により、患者はこれらの診断薬に容易にアクセスできるようになっています。多くの企業が、迅速な検査に対する需要から、分散型施設向けの感染症検査を開発しました。こうした新興国市場の開拓は、世界市場の成長に好影響を与えると思われます。

市場抑制要因

不十分な償還状況

不十分な診療報酬がポイントオブケア分子診断市場拡大の障壁となっています。診断企業が遭遇する主な困難の中には、メディケアや民間医療保険会社から診断検査の償還を受けることがあります。2018年、米国のメディケアは、ポイントオブケア分子アッセイなど一部の体外診断(IVD)検査の償還方法を変更しました。多様な利益団体が検査の価値を高め、適切な金額での償還を生み出す説得力のあるロビーとして機能する可能性があります。ポイントオブケア分子検査市場では、こうした変数がマイナスに作用すると予測されます。

製品とサービスの展望

製品・サービスに基づき、市場はアッセイ&キット、機器&分析装置、ソフトウェア&サービスに区分されます。2022年には、機器・分析装置部門が市場で大きな売上シェアを獲得しました。血漿、尿、喀痰、綿棒などのサンプルは分子分析装置を用いて検査されます。ほとんどの分子システムは、結核、クラミジア、HIV-1、HBV、HCVなど幅広い検査パラメーターを提供しています。その結果、結核や呼吸器疾患などにかかる人が増えるにつれて、機器と分析装置の市場は拡大しています。

エンドユーザー別展望

エンドユーザー別では、医院、病院・ICU、研究機関、その他に分類されます。2022年には、医院セグメントが市場で最大の収益シェアを記録しました。30分以内の迅速な所見が得られることから、POC分子検査&キットおよびシステムは、このような状況でしばしば使用されます。これにより迅速な診断が可能になり、医師は患者の状態を迅速に判断したり追跡したりすることができます。

技術の展望

技術別に見ると、市場はRT-PCR、等温核酸増幅技術(INAAT)、その他の技術に分けられます。INAAT分野は、2022年の市場で顕著な収益シェアを記録しました。慢性疾患の有病率上昇と高齢化の結果、INAAT(Isothermal Nucleic Acid Amplification Technology)は成長すると予測されています。PCRよりもINAATの採用が増加し、手頃な価格で効率的な診断手順への需要が高まっていることも、このセグメントの拡大を後押しする主な要因です。

用途の展望

用途別では、市場は呼吸器疾患、性感染症、病院感染症、肝炎、がん、消化器疾患、その他に二分されます。2022年には、呼吸器疾患分野が最も高い収益シェアを獲得し、市場を独占しました。感染症の頻度の増加、これらの疾患の早期診断と特定に対するニーズの高まりが、この市場セグメントの拡大を後押しする主な要因です。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が最大の収益シェアで市場をリードしました。市場拡大に影響を与える主な要因の1つは、地域のヘルスケアシステムに対する悪性腫瘍や感染症の負荷が大きいことです。同地域におけるPOC分子診断市場の開拓を後押しすると予測されるその他の要因としては、整備されたヘルスケアインフラの存在や、洗練された技術の受け入れが進んでいることなどが挙げられます。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因

第3章 競合分析- 世界

  • KBVカーディナルマトリックス
  • 最近の業界全体の戦略的展開
    • 提携、協定、および契約
    • 製品の発売と製品の拡大
    • 買収と合併
  • 主要成功戦略
    • 主な戦略

第4章 世界のポイントオブケア分子診断市場:製品とサービス別

  • 世界のアッセイおよびキット市場:地域別
  • 世界の計測器および分析装置市場:地域別
  • 世界のソフトウェアおよびサービス市場:地域別

第5章 世界のポイントオブケア分子診断市場:エンドユーザー別

  • 世界の医師のオフィス市場:地域別
  • 世界の病院およびICU市場:地域別
  • 世界の調査機関市場:地域別
  • 世界のその他の市場:地域別

第6章 世界のポイントオブケア分子診断市場:技術別

  • 世界のRT-PCR市場:地域別
  • 世界の等温核酸増幅技術(INAAT)市場:地域別
  • 世界のその他の市場:地域別

第7章 世界のポイントオブケア分子診断市場:用途別

  • 世界の呼吸器疾患市場:地域別
  • 世界の院内感染症市場:地域別
  • 世界の性感染症市場:地域別
  • 世界のがん市場:地域別
  • 世界の肝炎市場:地域別
  • 世界の消化器疾患市場:地域別
  • 世界のその他の市場:地域別

第8章 世界のポイントオブケア分子診断市場:地域別

  • 北米
    • 北米の市場:国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場:国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場:国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場:国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第9章 企業プロファイル

  • Abbott Laboratories
  • Bayer AG
  • Thermo Fisher Scientific, Inc
  • F Hoffmann-La Roche Ltd.
  • BioMerieux SA
  • Qiagen NV
  • Danaher Corporation
  • Bio-Rad laboratories, Inc
  • Agilent Technologies, Inc
  • Nova Biomedical Corporation
図表

LIST OF TABLES

  • TABLE 1 Global Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 2 Global Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Point of Care Molecular Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions- Point of Care Molecular Diagnostics Market
  • TABLE 5 Acquisition and Mergers- Point of Care Molecular Diagnostics Market
  • TABLE 6 Global Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 7 Global Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 8 Global Assays & Kits Market by Region, 2019 - 2022, USD Million
  • TABLE 9 Global Assays & Kits Market by Region, 2023 - 2030, USD Million
  • TABLE 10 Global Instruments & Analyzers Market by Region, 2019 - 2022, USD Million
  • TABLE 11 Global Instruments & Analyzers Market by Region, 2023 - 2030, USD Million
  • TABLE 12 Global Software & Services Market by Region, 2019 - 2022, USD Million
  • TABLE 13 Global Software & Services Market by Region, 2023 - 2030, USD Million
  • TABLE 14 Global Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 15 Global Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 16 Global Physicians Offices Market by Region, 2019 - 2022, USD Million
  • TABLE 17 Global Physicians Offices Market by Region, 2023 - 2030, USD Million
  • TABLE 18 Global Hospitals & ICUs Market by Region, 2019 - 2022, USD Million
  • TABLE 19 Global Hospitals & ICUs Market by Region, 2023 - 2030, USD Million
  • TABLE 20 Global Research Institutes Market by Region, 2019 - 2022, USD Million
  • TABLE 21 Global Research Institutes Market by Region, 2023 - 2030, USD Million
  • TABLE 22 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 23 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 24 Global Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 25 Global Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 26 Global RT-PCR Market by Region, 2019 - 2022, USD Million
  • TABLE 27 Global RT-PCR Market by Region, 2023 - 2030, USD Million
  • TABLE 28 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Region, 2019 - 2022, USD Million
  • TABLE 29 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Region, 2023 - 2030, USD Million
  • TABLE 30 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 31 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 32 Global Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 33 Global Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 34 Global Respiratory Diseases Market by Region, 2019 - 2022, USD Million
  • TABLE 35 Global Respiratory Diseases Market by Region, 2023 - 2030, USD Million
  • TABLE 36 Global Hospital-acquired Infections Market by Region, 2019 - 2022, USD Million
  • TABLE 37 Global Hospital-acquired Infections Market by Region, 2023 - 2030, USD Million
  • TABLE 38 Global Sexually Transmitted Diseases Market by Region, 2019 - 2022, USD Million
  • TABLE 39 Global Sexually Transmitted Diseases Market by Region, 2023 - 2030, USD Million
  • TABLE 40 Global Cancer Market by Region, 2019 - 2022, USD Million
  • TABLE 41 Global Cancer Market by Region, 2023 - 2030, USD Million
  • TABLE 42 Global Hepatitis Market by Region, 2019 - 2022, USD Million
  • TABLE 43 Global Hepatitis Market by Region, 2023 - 2030, USD Million
  • TABLE 44 Global Gastrointestinal Disorders Market by Region, 2019 - 2022, USD Million
  • TABLE 45 Global Gastrointestinal Disorders Market by Region, 2023 - 2030, USD Million
  • TABLE 46 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 47 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 48 Global Point of Care Molecular Diagnostics Market by Region, 2019 - 2022, USD Million
  • TABLE 49 Global Point of Care Molecular Diagnostics Market by Region, 2023 - 2030, USD Million
  • TABLE 50 North America Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 51 North America Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 52 North America Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 53 North America Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 54 North America Assays & Kits Market by Country, 2019 - 2022, USD Million
  • TABLE 55 North America Assays & Kits Market by Country, 2023 - 2030, USD Million
  • TABLE 56 North America Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 57 North America Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 58 North America Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 59 North America Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 60 North America Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 61 North America Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 62 North America Physicians Offices Market by Country, 2019 - 2022, USD Million
  • TABLE 63 North America Physicians Offices Market by Country, 2023 - 2030, USD Million
  • TABLE 64 North America Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
  • TABLE 65 North America Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
  • TABLE 66 North America Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 67 North America Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 68 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 69 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 70 North America Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 71 North America Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 72 North America RT-PCR Market by Country, 2019 - 2022, USD Million
  • TABLE 73 North America RT-PCR Market by Country, 2023 - 2030, USD Million
  • TABLE 74 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
  • TABLE 75 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
  • TABLE 76 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 77 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 78 North America Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 79 North America Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 80 North America Respiratory Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 81 North America Respiratory Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 82 North America Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
  • TABLE 83 North America Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
  • TABLE 84 North America Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 85 North America Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 86 North America Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 87 North America Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 88 North America Hepatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 89 North America Hepatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 90 North America Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
  • TABLE 91 North America Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
  • TABLE 92 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 93 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 94 North America Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
  • TABLE 95 North America Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
  • TABLE 96 US Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 97 US Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 98 US Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 99 US Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 100 US Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 101 US Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 102 US Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 103 US Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 104 US Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 105 US Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 106 Canada Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 107 Canada Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 108 Canada Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 109 Canada Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 110 Canada Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 111 Canada Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 112 Canada Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 113 Canada Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 114 Canada Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 115 Canada Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 116 Mexico Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 117 Mexico Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 118 Mexico Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 119 Mexico Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 120 Mexico Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 121 Mexico Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 122 Mexico Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 123 Mexico Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 124 Mexico Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 125 Mexico Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 126 Rest of North America Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 127 Rest of North America Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 128 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 129 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 130 Rest of North America Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 131 Rest of North America Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 132 Rest of North America Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 133 Rest of North America Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 134 Rest of North America Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 135 Rest of North America Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 136 Europe Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 137 Europe Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 138 Europe Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 139 Europe Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 140 Europe Assays & Kits Market by Country, 2019 - 2022, USD Million
  • TABLE 141 Europe Assays & Kits Market by Country, 2023 - 2030, USD Million
  • TABLE 142 Europe Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 143 Europe Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 144 Europe Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 145 Europe Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 146 Europe Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 147 Europe Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 148 Europe Physicians Offices Market by Country, 2019 - 2022, USD Million
  • TABLE 149 Europe Physicians Offices Market by Country, 2023 - 2030, USD Million
  • TABLE 150 Europe Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
  • TABLE 151 Europe Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
  • TABLE 152 Europe Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 153 Europe Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 154 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 155 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 156 Europe Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 157 Europe Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 158 Europe RT-PCR Market by Country, 2019 - 2022, USD Million
  • TABLE 159 Europe RT-PCR Market by Country, 2023 - 2030, USD Million
  • TABLE 160 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
  • TABLE 161 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
  • TABLE 162 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 163 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 164 Europe Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 165 Europe Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 166 Europe Respiratory Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 167 Europe Respiratory Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 168 Europe Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
  • TABLE 169 Europe Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
  • TABLE 170 Europe Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 171 Europe Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 172 Europe Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 173 Europe Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 174 Europe Hepatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 175 Europe Hepatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 176 Europe Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
  • TABLE 177 Europe Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
  • TABLE 178 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 179 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 180 Europe Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
  • TABLE 181 Europe Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
  • TABLE 182 Germany Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 183 Germany Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 184 Germany Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 185 Germany Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 186 Germany Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 187 Germany Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 188 Germany Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 189 Germany Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 190 Germany Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 191 Germany Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 192 UK Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 193 UK Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 194 UK Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 195 UK Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 196 UK Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 197 UK Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 198 UK Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 199 UK Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 200 UK Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 201 UK Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 202 France Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 203 France Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 204 France Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 205 France Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 206 France Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 207 France Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 208 France Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 209 France Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 210 France Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 211 France Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 212 Russia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 213 Russia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 214 Russia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 215 Russia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 216 Russia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 217 Russia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 218 Russia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 219 Russia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 220 Russia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 221 Russia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 222 Spain Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 223 Spain Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 224 Spain Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 225 Spain Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 226 Spain Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 227 Spain Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 228 Spain Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 229 Spain Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 230 Spain Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 231 Spain Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 232 Italy Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 233 Italy Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 234 Italy Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 235 Italy Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 236 Italy Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 237 Italy Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 238 Italy Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 239 Italy Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 240 Italy Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 241 Italy Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 242 Rest of Europe Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 243 Rest of Europe Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 244 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 245 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 246 Rest of Europe Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 247 Rest of Europe Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 248 Rest of Europe Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 249 Rest of Europe Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 250 Rest of Europe Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 251 Rest of Europe Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 252 Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 253 Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 254 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 255 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 256 Asia Pacific Assays & Kits Market by Country, 2019 - 2022, USD Million
  • TABLE 257 Asia Pacific Assays & Kits Market by Country, 2023 - 2030, USD Million
  • TABLE 258 Asia Pacific Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 259 Asia Pacific Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 260 Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 261 Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 262 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 263 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 264 Asia Pacific Physicians Offices Market by Country, 2019 - 2022, USD Million
  • TABLE 265 Asia Pacific Physicians Offices Market by Country, 2023 - 2030, USD Million
  • TABLE 266 Asia Pacific Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
  • TABLE 267 Asia Pacific Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
  • TABLE 268 Asia Pacific Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 269 Asia Pacific Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 270 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 271 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 272 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 273 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 274 Asia Pacific RT-PCR Market by Country, 2019 - 2022, USD Million
  • TABLE 275 Asia Pacific RT-PCR Market by Country, 2023 - 2030, USD Million
  • TABLE 276 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
  • TABLE 277 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
  • TABLE 278 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 279 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 280 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 281 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 282 Asia Pacific Respiratory Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 283 Asia Pacific Respiratory Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 284 Asia Pacific Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
  • TABLE 285 Asia Pacific Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
  • TABLE 286 Asia Pacific Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 287 Asia Pacific Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 288 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 289 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 290 Asia Pacific Hepatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 291 Asia Pacific Hepatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 292 Asia Pacific Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
  • TABLE 293 Asia Pacific Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
  • TABLE 294 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 295 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 296 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
  • TABLE 297 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
  • TABLE 298 China Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 299 China Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 300 China Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 301 China Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 302 China Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 303 China Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 304 China Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 305 China Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 306 China Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 307 China Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 308 Japan Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 309 Japan Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 310 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 311 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 312 Japan Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 313 Japan Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 314 Japan Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 315 Japan Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 316 Japan Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 317 Japan Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 318 India Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 319 India Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 320 India Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 321 India Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 322 India Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 323 India Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 324 India Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 325 India Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 326 India Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 327 India Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 328 South Korea Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 329 South Korea Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 330 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 331 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 332 South Korea Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 333 South Korea Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 334 South Korea Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 335 South Korea Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 336 South Korea Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 337 South Korea Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 338 Singapore Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 339 Singapore Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 340 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 341 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 342 Singapore Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 343 Singapore Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 344 Singapore Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 345 Singapore Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 346 Singapore Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 347 Singapore Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 348 Malaysia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 349 Malaysia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 350 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 351 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 352 Malaysia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 353 Malaysia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 354 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 355 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 356 Malaysia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 357 Malaysia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 358 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 359 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 360 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 361 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 362 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 363 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 364 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 365 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 366 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 367 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 368 LAMEA Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 369 LAMEA Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 370 LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 371 LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 372 LAMEA Assays & Kits Market by Country, 2019 - 2022, USD Million
  • TABLE 373 LAMEA Assays & Kits Market by Country, 2023 - 2030, USD Million
  • TABLE 374 LAMEA Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 375 LAMEA Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 376 LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 377 LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 378 LAMEA Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 379 LAMEA Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 380 LAMEA Physicians Offices Market by Country, 2019 - 2022, USD Million
  • TABLE 381 LAMEA Physicians Offices Market by Country, 2023 - 2030, USD Million
  • TABLE 382 LAMEA Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
  • TABLE 383 LAMEA Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
  • TABLE 384 LAMEA Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 385 LAMEA Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 386 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 387 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 388 LAMEA Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 389 LAMEA Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 390 LAMEA RT-PCR Market by Country, 2019 - 2022, USD Million
  • TABLE 391 LAMEA RT-PCR Market by Country, 2023 - 2030, USD Million
  • TABLE 392 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
  • TABLE 393 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
  • TABLE 394 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 395 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 396 LAMEA Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 397 LAMEA Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 398 LAMEA Respiratory Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 399 LAMEA Respiratory Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 400 LAMEA Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
  • TABLE 401 LAMEA Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
  • TABLE 402 LAMEA Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 403 LAMEA Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 404 LAMEA Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 405 LAMEA Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 406 LAMEA Hepatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 407 LAMEA Hepatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 408 LAMEA Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
  • TABLE 409 LAMEA Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
  • TABLE 410 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 411 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 412 LAMEA Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
  • TABLE 413 LAMEA Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
  • TABLE 414 Brazil Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 415 Brazil Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 416 Brazil Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 417 Brazil Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 418 Brazil Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 419 Brazil Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 420 Brazil Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 421 Brazil Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 422 Brazil Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 423 Brazil Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 424 Argentina Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 425 Argentina Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 426 Argentina Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 427 Argentina Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 428 Argentina Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 429 Argentina Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 430 Argentina Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 431 Argentina Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 432 Argentina Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 433 Argentina Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 434 UAE Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 435 UAE Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 436 UAE Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 437 UAE Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 438 UAE Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 439 UAE Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 440 UAE Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 441 UAE Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 442 UAE Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 443 UAE Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 444 Saudi Arabia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 445 Saudi Arabia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 446 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 447 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 448 Saudi Arabia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 449 Saudi Arabia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 450 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 451 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 452 Saudi Arabia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 453 Saudi Arabia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 454 South Africa Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 455 South Africa Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 456 South Africa Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 457 South Africa Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 458 South Africa Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 459 South Africa Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 460 South Africa Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 461 South Africa Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 462 South Africa Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 463 South Africa Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 464 Nigeria Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 465 Nigeria Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 466 Nigeria Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 467 Nigeria Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 468 Nigeria Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 469 Nigeria Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 470 Nigeria Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 471 Nigeria Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 472 Nigeria Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 473 Nigeria Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 474 Rest of LAMEA Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 475 Rest of LAMEA Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 476 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 477 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 478 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 479 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 480 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 481 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 482 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 483 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 484 Key Information - Abbott Laboratories
  • TABLE 485 Key Information - Bayer AG
  • TABLE 486 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 487 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 488 Key information - BioMerieux S.A.
  • TABLE 489 Key Information - Qiagen N.V.
  • TABLE 490 Key Information - Danaher Corporation
  • TABLE 491 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 492 key Information - Agilent Technologies, Inc.
  • TABLE 493 key information - Nova Biomedical Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
  • FIG 4 Global Point of Care Molecular Diagnostics Market share by Product & Service, 2022
  • FIG 5 Global Point of Care Molecular Diagnostics Market share by Product & Service, 2030
  • FIG 6 Global Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2030, USD Million
  • FIG 7 Global Point of Care Molecular Diagnostics Market share by End User, 2022
  • FIG 8 Global Point of Care Molecular Diagnostics Market share by End User, 2030
  • FIG 9 Global Point of Care Molecular Diagnostics Market by End User, 2019 - 2030, USD Million
  • FIG 10 Global Point of Care Molecular Diagnostics Market share by Technology, 2022
  • FIG 11 Global Point of Care Molecular Diagnostics Market share by Technology, 2030
  • FIG 12 Global Point of Care Molecular Diagnostics Market by Technology, 2019 - 2030, USD Million
  • FIG 13 Global Point of Care Molecular Diagnostics Market share by Application, 2022
  • FIG 14 Global Point of Care Molecular Diagnostics Market share by Application, 2030
  • FIG 15 Global Point of Care Molecular Diagnostics Market by Application, 2019 - 2030, USD Million
  • FIG 16 Global Point of Care Molecular Diagnostics Market share by Region, 2022
  • FIG 17 Global Point of Care Molecular Diagnostics Market share by Region, 2030
  • FIG 18 Global Point of Care Molecular Diagnostics Market by Region, 2019 - 2030, USD Million
  • FIG 19 Swot Analysis: Abbott Laboratories
  • FIG 20 Swot Analysis: Bayer AG
  • FIG 21 Swot Analysis: Thermo Fisher Scientific, Inc.
  • FIG 22 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
目次

The Global Point of Care Molecular Diagnostics Market size is expected to reach $4.1 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.

A new generation of POC devices that will change gastrointestinal diagnostic routes has been made possible by recent improvements in analytical methods. Hence, Gastrointestinal Disorders segment accounted for $113.1 million revenue in the market in 2022. About one-third of people in North European and North American populations still have Heliobacter pylori infection, compared to prevalence rates of more than 50% in South and East Europe, South America, and Asia. Immigrants from nations with high H. pylori prevalence continue to have a high prevalence of the stomach virus.

However, the younger generations' lower infection rates imply that the prevalence of H. pylori will continue to fall over the next several decades. The most significant risk factors for H. pylori infection are low socioeconomic situations throughout childhood. A hectic schedule is bringing on gastric ailments, an increase in the style of life, and poor eating habits. In 2018, there were reportedly 4.8 million new cases of cancer and 3.4 million deaths from it, according to the WHO, making up 26% of the burden of cancer incidence globally and 35% of all cancer-related fatalities. As a result, the prevalence of stomach illnesses would spur market expansion throughout the forecasted decade.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In March, 2023, QIAGEN N.V. formed a partnership with Servier to develop and validate a real-time in vitro PCR test that can be used to detect IDH1 gene mutations in AML patients in whole blood and bone marrow aspirates. Additionally, In February, 2021, Agilent Technologies formed a partnership with Mammoth Biosciences to offer a simple workflow to address the specific needs of high-throughput clinical testing laboratories.

Based on the Analysis presented in the KBV Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunner in the Market. In June, 2020, Roche formed a partnership with SpeeDx to enable Roche Diagnostics to offer clinicians critical and advanced tools for the detection of antibiotic resistance in patients with sexually transmitted infections. Companies such as Danaher Corporation, Thermo Fisher Scientific, Inc., Abbott Laboratories are some of the key innovators in the Market.

Market Growth Factors

An increasing number of older people

In practically every country, the percentage of older adults in the population is growing. WHO estimates that by 2030, 1 in 6 individuals worldwide will be 60 or older. By this point, there will be 1.4 billion people over 60, up from 1 billion in 2020. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Over the projection period, there will be an increase in demand for point-of-care molecular diagnostics due to the increased prevalence of respiratory illnesses and disorders among the aging population globally.

Decentralized Healthcare System Proliferation to Support Market Expansion

Due to the fast diagnostic outcomes necessary for precise and efficient treatment choices, point-of-care testing has become essential for patient-centric healthcare. Patients now have easy access to these diagnostics due to a change from centralized point-of-care testing to decentralized testing for chronic, infectious, and chronic conditions. Many players have created infectious disease tests for dispersed sites due to the demand for quick turnaround testing. These developments will favorably impact the growth of the worldwide market.

Market Restraining Factors

Poor reimbursement circumstances

Inadequate reimbursements are a barrier to the point-of-care molecular diagnostics market's expansion. Among the major difficulties diagnostic firms encounter is receiving reimbursement for diagnostic tests from Medicare and commercial health insurers. In 2018, Medicare in the US changed how some in vitro diagnostic (IVD) tests, such as point-of-care molecular assays, were reimbursed. Diverse interest groups could increase a test's worth and serve as a persuasive lobby to generate reimbursement at the right amount. On the market for point-of-care molecular testing, these variables are projected to have a negative effect.

Product and Services Outlook

Based on product & service, the market is segmented into assays & kits, instruments & analyzers, and software & service. In 2022, the instruments & analyzers segment gained a sizable revenue share in the market. Plasma, urine, sputum, and swab samples are tested using molecular analyzers. Most molecular systems provide a broad range of test parameters, including those for TB, Chlamydia, HIV-1, HBV, and HCV. As a result, the equipment and analyzers market is expanding as more people get TBL, respiratory disorders, etc.

End-user Outlook

By end-user, the market is categorized into physicians' offices, hospitals & ICUs, research institutes, and others. In 2022, the physicians' offices segment registered the largest revenue share in market. Due to its ability to provide quick findings within 30 minutes, POC molecular test & kits and systems are often used in these circumstances. This facilitates prompt diagnosis and enables doctors to determine or track a patient's status quickly.

Technology Outlook

By technology, the market is divided into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and other technologies. The INAAT segment recorded a remarkable revenue share in the market in 2022. As a result of the rising prevalence of chronic diseases and an aging population, INAAT (Isothermal Nucleic Acid Amplification Technology) is projected to grow. An increase in the adoption of INAAT over PCR and a rise in demand for affordable and efficient diagnostic procedures are other key factors fueling the segment's expansion.

Application Outlook

On the basis of application, the market is bifurcated into respiratory diseases, sexually transmitted diseases, hospital acquired infections, hepatitis, cancer, gastrointestinal disorders, and others. In 2022, the respiratory diseases segment dominated the market by generating the highest revenue share. The increasing frequency of infectious illnesses and the rising need for early diagnosis and identification of these diseases are the main factors fueling the expansion of this market segment.

Regional Outlook

Region wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market with the maximum revenue share. One of the main factors influencing market expansion is the heavy load of malignancies and infectious illnesses on local healthcare systems. Other factors projected to boost the development of the point-of-care molecular diagnostics market in the area include the existence of a well-developed healthcare infrastructure and the rising acceptance of sophisticated technologies.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation

Recent Strategies Deployed in Point of Care Molecular Diagnostics Market

Partnerships, Collaboration and Agreements:

Mar-2023: QIAGEN N.V. formed a partnership with Servier, a global pharmaceutical group. The partnership aimed to develop and validate a real-time in vitro PCR test that can be used to detect IDH1 gene mutations in AML patients in whole blood and bone marrow aspirates.

Apr-2023: BioMerieux S.A. partnered with Oxford Nanopore Technologies plc, a developer and seller of nanopore sequencing products for the direct, electronic analysis of single molecules. The partnership aimed to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.

Jan-2023: QIAGEN entered into a partnership with Helix, a California-based population genomics leader. Through this partnership, the company would leverage the Helix Laboratory Platform to offer innovative solutions for biopharmaceutical customers.

Feb-2021: Agilent Technologies formed a partnership with Mammoth Biosciences, a private biotechnology company. Through this partnership, the company aimed to offer a simple workflow to address the specific needs of high-throughput clinical testing laboratories.

Product Launch and Product Expansions:

Oct-2022: Roche revealed SARS-CoV-2 Rapid Antibody Test 2.0 for healthcare professionals to identify patients who have developed antibodies against the virus, indicating previous infection or vaccination.

Nov-2021: Roche unveiled cobas 5800 System, a new molecular laboratory instrument. The new system addresses challenges faced by laboratories from the increase in patient testing, reimbursement complexities, and the need for a more diverse testing menu while providing meaningful and timely results.

Acquisitions and Merger:

Aug-2022: Bio-Rad acquired Curiosity Diagnostics, a late-stage, pre-commercial platform company. This acquisition aimed at working closely to bring the latest generation of rapid PCR systems to market. Curiosity's PCR platform, PCR|ONE would offer a streamlined workflow as well as rapid turnaround times and is predicted to extend its reach beyond high-complexity labs into near-patient molecular diagnostics labs.

May-2022: BioMerieux completed the acquisition of Specific Diagnostics, a medical device startup that has developed in vitro diagnostic systems. The acquisition would enable the company to further develop its leadership in clinical microbiology and strengthen its fight against Antimicrobial Resistance.

May-2021: Roche took over GenMark Diagnostics, a leading vendor of multiplex molecular diagnostic solutions. This acquisition aimed to expand Roche's molecular diagnostics offerings to incorporate solutions with the capability to offer lifesaving information to patients, as well as their healthcare providers, rapidly.

Feb-2021: Thermo Fisher Scientific acquired Mesa Biotech, a healthcare test, and data company. The acquisition aimed at rapidly scaling manufacturing volume, driving cost efficiencies as well as bringing much-needed diagnostics to the market faster and at an expanded scale.

Scope of the Study

Market Segments covered in the Report:

By Product & Service

  • Assays & Kits
  • Instruments & Analyzers
  • Software & Services Surveillance & Monitoring

By End User

  • Physicians Offices
  • Hospitals & ICUs
  • Research Institutes
  • Others

By Technology

  • RT-PCR
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

By Application

  • Respiratory Diseases
  • Hospital-acquired Infections
  • Sexually Transmitted Diseases
  • Cancer
  • Hepatitis
  • Gastrointestinal Disorders
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Nova Biomedical Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Point of Care Molecular Diagnostics Market, by Product & Service
    • 1.4.2 Global Point of Care Molecular Diagnostics Market, by End User
    • 1.4.3 Global Point of Care Molecular Diagnostics Market, by Technology
    • 1.4.4 Global Point of Care Molecular Diagnostics Market, by Application
    • 1.4.5 Global Point of Care Molecular Diagnostics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Global Point of Care Molecular Diagnostics Market by Product & Service

  • 4.1 Global Assays & Kits Market by Region
  • 4.2 Global Instruments & Analyzers Market by Region
  • 4.3 Global Software & Services Market by Region

Chapter 5. Global Point of Care Molecular Diagnostics Market by End User

  • 5.1 Global Physicians Offices Market by Region
  • 5.2 Global Hospitals & ICUs Market by Region
  • 5.3 Global Research Institutes Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Point of Care Molecular Diagnostics Market by Technology

  • 6.1 Global RT-PCR Market by Region
  • 6.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Region
  • 6.3 Global Others Market by Region

Chapter 7. Global Point of Care Molecular Diagnostics Market by Application

  • 7.1 Global Respiratory Diseases Market by Region
  • 7.2 Global Hospital-acquired Infections Market by Region
  • 7.3 Global Sexually Transmitted Diseases Market by Region
  • 7.4 Global Cancer Market by Region
  • 7.5 Global Hepatitis Market by Region
  • 7.6 Global Gastrointestinal Disorders Market by Region
  • 7.7 Global Others Market by Region

Chapter 8. Global Point of Care Molecular Diagnostics Market by Region

  • 8.1 North America Point of Care Molecular Diagnostics Market
    • 8.1.1 North America Point of Care Molecular Diagnostics Market by Product & Service
      • 8.1.1.1 North America Assays & Kits Market by Country
      • 8.1.1.2 North America Instruments & Analyzers Market by Country
      • 8.1.1.3 North America Software & Services Market by Country
    • 8.1.2 North America Point of Care Molecular Diagnostics Market by End User
      • 8.1.2.1 North America Physicians Offices Market by Country
      • 8.1.2.2 North America Hospitals & ICUs Market by Country
      • 8.1.2.3 North America Research Institutes Market by Country
      • 8.1.2.4 North America Others Market by Country
    • 8.1.3 North America Point of Care Molecular Diagnostics Market by Technology
      • 8.1.3.1 North America RT-PCR Market by Country
      • 8.1.3.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
      • 8.1.3.3 North America Others Market by Country
    • 8.1.4 North America Point of Care Molecular Diagnostics Market by Application
      • 8.1.4.1 North America Respiratory Diseases Market by Country
      • 8.1.4.2 North America Hospital-acquired Infections Market by Country
      • 8.1.4.3 North America Sexually Transmitted Diseases Market by Country
      • 8.1.4.4 North America Cancer Market by Country
      • 8.1.4.5 North America Hepatitis Market by Country
      • 8.1.4.6 North America Gastrointestinal Disorders Market by Country
      • 8.1.4.7 North America Others Market by Country
    • 8.1.5 North America Point of Care Molecular Diagnostics Market by Country
      • 8.1.5.1 US Point of Care Molecular Diagnostics Market
        • 8.1.5.1.1 US Point of Care Molecular Diagnostics Market by Product & Service
        • 8.1.5.1.2 US Point of Care Molecular Diagnostics Market by End User
        • 8.1.5.1.3 US Point of Care Molecular Diagnostics Market by Technology
        • 8.1.5.1.4 US Point of Care Molecular Diagnostics Market by Application
      • 8.1.5.2 Canada Point of Care Molecular Diagnostics Market
        • 8.1.5.2.1 Canada Point of Care Molecular Diagnostics Market by Product & Service
        • 8.1.5.2.2 Canada Point of Care Molecular Diagnostics Market by End User
        • 8.1.5.2.3 Canada Point of Care Molecular Diagnostics Market by Technology
        • 8.1.5.2.4 Canada Point of Care Molecular Diagnostics Market by Application
      • 8.1.5.3 Mexico Point of Care Molecular Diagnostics Market
        • 8.1.5.3.1 Mexico Point of Care Molecular Diagnostics Market by Product & Service
        • 8.1.5.3.2 Mexico Point of Care Molecular Diagnostics Market by End User
        • 8.1.5.3.3 Mexico Point of Care Molecular Diagnostics Market by Technology
        • 8.1.5.3.4 Mexico Point of Care Molecular Diagnostics Market by Application
      • 8.1.5.4 Rest of North America Point of Care Molecular Diagnostics Market
        • 8.1.5.4.1 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service
        • 8.1.5.4.2 Rest of North America Point of Care Molecular Diagnostics Market by End User
        • 8.1.5.4.3 Rest of North America Point of Care Molecular Diagnostics Market by Technology
        • 8.1.5.4.4 Rest of North America Point of Care Molecular Diagnostics Market by Application
  • 8.2 Europe Point of Care Molecular Diagnostics Market
    • 8.2.1 Europe Point of Care Molecular Diagnostics Market by Product & Service
      • 8.2.1.1 Europe Assays & Kits Market by Country
      • 8.2.1.2 Europe Instruments & Analyzers Market by Country
      • 8.2.1.3 Europe Software & Services Market by Country
    • 8.2.2 Europe Point of Care Molecular Diagnostics Market by End User
      • 8.2.2.1 Europe Physicians Offices Market by Country
      • 8.2.2.2 Europe Hospitals & ICUs Market by Country
      • 8.2.2.3 Europe Research Institutes Market by Country
      • 8.2.2.4 Europe Others Market by Country
    • 8.2.3 Europe Point of Care Molecular Diagnostics Market by Technology
      • 8.2.3.1 Europe RT-PCR Market by Country
      • 8.2.3.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
      • 8.2.3.3 Europe Others Market by Country
    • 8.2.4 Europe Point of Care Molecular Diagnostics Market by Application
      • 8.2.4.1 Europe Respiratory Diseases Market by Country
      • 8.2.4.2 Europe Hospital-acquired Infections Market by Country
      • 8.2.4.3 Europe Sexually Transmitted Diseases Market by Country
      • 8.2.4.4 Europe Cancer Market by Country
      • 8.2.4.5 Europe Hepatitis Market by Country
      • 8.2.4.6 Europe Gastrointestinal Disorders Market by Country
      • 8.2.4.7 Europe Others Market by Country
    • 8.2.5 Europe Point of Care Molecular Diagnostics Market by Country
      • 8.2.5.1 Germany Point of Care Molecular Diagnostics Market
        • 8.2.5.1.1 Germany Point of Care Molecular Diagnostics Market by Product & Service
        • 8.2.5.1.2 Germany Point of Care Molecular Diagnostics Market by End User
        • 8.2.5.1.3 Germany Point of Care Molecular Diagnostics Market by Technology
        • 8.2.5.1.4 Germany Point of Care Molecular Diagnostics Market by Application
      • 8.2.5.2 UK Point of Care Molecular Diagnostics Market
        • 8.2.5.2.1 UK Point of Care Molecular Diagnostics Market by Product & Service
        • 8.2.5.2.2 UK Point of Care Molecular Diagnostics Market by End User
        • 8.2.5.2.3 UK Point of Care Molecular Diagnostics Market by Technology
        • 8.2.5.2.4 UK Point of Care Molecular Diagnostics Market by Application
      • 8.2.5.3 France Point of Care Molecular Diagnostics Market
        • 8.2.5.3.1 France Point of Care Molecular Diagnostics Market by Product & Service
        • 8.2.5.3.2 France Point of Care Molecular Diagnostics Market by End User
        • 8.2.5.3.3 France Point of Care Molecular Diagnostics Market by Technology
        • 8.2.5.3.4 France Point of Care Molecular Diagnostics Market by Application
      • 8.2.5.4 Russia Point of Care Molecular Diagnostics Market
        • 8.2.5.4.1 Russia Point of Care Molecular Diagnostics Market by Product & Service
        • 8.2.5.4.2 Russia Point of Care Molecular Diagnostics Market by End User
        • 8.2.5.4.3 Russia Point of Care Molecular Diagnostics Market by Technology
        • 8.2.5.4.4 Russia Point of Care Molecular Diagnostics Market by Application
      • 8.2.5.5 Spain Point of Care Molecular Diagnostics Market
        • 8.2.5.5.1 Spain Point of Care Molecular Diagnostics Market by Product & Service
        • 8.2.5.5.2 Spain Point of Care Molecular Diagnostics Market by End User
        • 8.2.5.5.3 Spain Point of Care Molecular Diagnostics Market by Technology
        • 8.2.5.5.4 Spain Point of Care Molecular Diagnostics Market by Application
      • 8.2.5.6 Italy Point of Care Molecular Diagnostics Market
        • 8.2.5.6.1 Italy Point of Care Molecular Diagnostics Market by Product & Service
        • 8.2.5.6.2 Italy Point of Care Molecular Diagnostics Market by End User
        • 8.2.5.6.3 Italy Point of Care Molecular Diagnostics Market by Technology
        • 8.2.5.6.4 Italy Point of Care Molecular Diagnostics Market by Application
      • 8.2.5.7 Rest of Europe Point of Care Molecular Diagnostics Market
        • 8.2.5.7.1 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service
        • 8.2.5.7.2 Rest of Europe Point of Care Molecular Diagnostics Market by End User
        • 8.2.5.7.3 Rest of Europe Point of Care Molecular Diagnostics Market by Technology
        • 8.2.5.7.4 Rest of Europe Point of Care Molecular Diagnostics Market by Application
  • 8.3 Asia Pacific Point of Care Molecular Diagnostics Market
    • 8.3.1 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
      • 8.3.1.1 Asia Pacific Assays & Kits Market by Country
      • 8.3.1.2 Asia Pacific Instruments & Analyzers Market by Country
      • 8.3.1.3 Asia Pacific Software & Services Market by Country
    • 8.3.2 Asia Pacific Point of Care Molecular Diagnostics Market by End User
      • 8.3.2.1 Asia Pacific Physicians Offices Market by Country
      • 8.3.2.2 Asia Pacific Hospitals & ICUs Market by Country
      • 8.3.2.3 Asia Pacific Research Institutes Market by Country
      • 8.3.2.4 Asia Pacific Others Market by Country
    • 8.3.3 Asia Pacific Point of Care Molecular Diagnostics Market by Technology
      • 8.3.3.1 Asia Pacific RT-PCR Market by Country
      • 8.3.3.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
      • 8.3.3.3 Asia Pacific Others Market by Country
    • 8.3.4 Asia Pacific Point of Care Molecular Diagnostics Market by Application
      • 8.3.4.1 Asia Pacific Respiratory Diseases Market by Country
      • 8.3.4.2 Asia Pacific Hospital-acquired Infections Market by Country
      • 8.3.4.3 Asia Pacific Sexually Transmitted Diseases Market by Country
      • 8.3.4.4 Asia Pacific Cancer Market by Country
      • 8.3.4.5 Asia Pacific Hepatitis Market by Country
      • 8.3.4.6 Asia Pacific Gastrointestinal Disorders Market by Country
      • 8.3.4.7 Asia Pacific Others Market by Country
    • 8.3.5 Asia Pacific Point of Care Molecular Diagnostics Market by Country
      • 8.3.5.1 China Point of Care Molecular Diagnostics Market
        • 8.3.5.1.1 China Point of Care Molecular Diagnostics Market by Product & Service
        • 8.3.5.1.2 China Point of Care Molecular Diagnostics Market by End User
        • 8.3.5.1.3 China Point of Care Molecular Diagnostics Market by Technology
        • 8.3.5.1.4 China Point of Care Molecular Diagnostics Market by Application
      • 8.3.5.2 Japan Point of Care Molecular Diagnostics Market
        • 8.3.5.2.1 Japan Point of Care Molecular Diagnostics Market by Product & Service
        • 8.3.5.2.2 Japan Point of Care Molecular Diagnostics Market by End User
        • 8.3.5.2.3 Japan Point of Care Molecular Diagnostics Market by Technology
        • 8.3.5.2.4 Japan Point of Care Molecular Diagnostics Market by Application
      • 8.3.5.3 India Point of Care Molecular Diagnostics Market
        • 8.3.5.3.1 India Point of Care Molecular Diagnostics Market by Product & Service
        • 8.3.5.3.2 India Point of Care Molecular Diagnostics Market by End User
        • 8.3.5.3.3 India Point of Care Molecular Diagnostics Market by Technology
        • 8.3.5.3.4 India Point of Care Molecular Diagnostics Market by Application
      • 8.3.5.4 South Korea Point of Care Molecular Diagnostics Market
        • 8.3.5.4.1 South Korea Point of Care Molecular Diagnostics Market by Product & Service
        • 8.3.5.4.2 South Korea Point of Care Molecular Diagnostics Market by End User
        • 8.3.5.4.3 South Korea Point of Care Molecular Diagnostics Market by Technology
        • 8.3.5.4.4 South Korea Point of Care Molecular Diagnostics Market by Application
      • 8.3.5.5 Singapore Point of Care Molecular Diagnostics Market
        • 8.3.5.5.1 Singapore Point of Care Molecular Diagnostics Market by Product & Service
        • 8.3.5.5.2 Singapore Point of Care Molecular Diagnostics Market by End User
        • 8.3.5.5.3 Singapore Point of Care Molecular Diagnostics Market by Technology
        • 8.3.5.5.4 Singapore Point of Care Molecular Diagnostics Market by Application
      • 8.3.5.6 Malaysia Point of Care Molecular Diagnostics Market
        • 8.3.5.6.1 Malaysia Point of Care Molecular Diagnostics Market by Product & Service
        • 8.3.5.6.2 Malaysia Point of Care Molecular Diagnostics Market by End User
        • 8.3.5.6.3 Malaysia Point of Care Molecular Diagnostics Market by Technology
        • 8.3.5.6.4 Malaysia Point of Care Molecular Diagnostics Market by Application
      • 8.3.5.7 Rest of Asia Pacific Point of Care Molecular Diagnostics Market
        • 8.3.5.7.1 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
        • 8.3.5.7.2 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User
        • 8.3.5.7.3 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology
        • 8.3.5.7.4 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application
  • 8.4 LAMEA Point of Care Molecular Diagnostics Market
    • 8.4.1 LAMEA Point of Care Molecular Diagnostics Market by Product & Service
      • 8.4.1.1 LAMEA Assays & Kits Market by Country
      • 8.4.1.2 LAMEA Instruments & Analyzers Market by Country
      • 8.4.1.3 LAMEA Software & Services Market by Country
    • 8.4.2 LAMEA Point of Care Molecular Diagnostics Market by End User
      • 8.4.2.1 LAMEA Physicians Offices Market by Country
      • 8.4.2.2 LAMEA Hospitals & ICUs Market by Country
      • 8.4.2.3 LAMEA Research Institutes Market by Country
      • 8.4.2.4 LAMEA Others Market by Country
    • 8.4.3 LAMEA Point of Care Molecular Diagnostics Market by Technology
      • 8.4.3.1 LAMEA RT-PCR Market by Country
      • 8.4.3.2 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
      • 8.4.3.3 LAMEA Others Market by Country
    • 8.4.4 LAMEA Point of Care Molecular Diagnostics Market by Application
      • 8.4.4.1 LAMEA Respiratory Diseases Market by Country
      • 8.4.4.2 LAMEA Hospital-acquired Infections Market by Country
      • 8.4.4.3 LAMEA Sexually Transmitted Diseases Market by Country
      • 8.4.4.4 LAMEA Cancer Market by Country
      • 8.4.4.5 LAMEA Hepatitis Market by Country
      • 8.4.4.6 LAMEA Gastrointestinal Disorders Market by Country
      • 8.4.4.7 LAMEA Others Market by Country
    • 8.4.5 LAMEA Point of Care Molecular Diagnostics Market by Country
      • 8.4.5.1 Brazil Point of Care Molecular Diagnostics Market
        • 8.4.5.1.1 Brazil Point of Care Molecular Diagnostics Market by Product & Service
        • 8.4.5.1.2 Brazil Point of Care Molecular Diagnostics Market by End User
        • 8.4.5.1.3 Brazil Point of Care Molecular Diagnostics Market by Technology
        • 8.4.5.1.4 Brazil Point of Care Molecular Diagnostics Market by Application
      • 8.4.5.2 Argentina Point of Care Molecular Diagnostics Market
        • 8.4.5.2.1 Argentina Point of Care Molecular Diagnostics Market by Product & Service
        • 8.4.5.2.2 Argentina Point of Care Molecular Diagnostics Market by End User
        • 8.4.5.2.3 Argentina Point of Care Molecular Diagnostics Market by Technology
        • 8.4.5.2.4 Argentina Point of Care Molecular Diagnostics Market by Application
      • 8.4.5.3 UAE Point of Care Molecular Diagnostics Market
        • 8.4.5.3.1 UAE Point of Care Molecular Diagnostics Market by Product & Service
        • 8.4.5.3.2 UAE Point of Care Molecular Diagnostics Market by End User
        • 8.4.5.3.3 UAE Point of Care Molecular Diagnostics Market by Technology
        • 8.4.5.3.4 UAE Point of Care Molecular Diagnostics Market by Application
      • 8.4.5.4 Saudi Arabia Point of Care Molecular Diagnostics Market
        • 8.4.5.4.1 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service
        • 8.4.5.4.2 Saudi Arabia Point of Care Molecular Diagnostics Market by End User
        • 8.4.5.4.3 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology
        • 8.4.5.4.4 Saudi Arabia Point of Care Molecular Diagnostics Market by Application
      • 8.4.5.5 South Africa Point of Care Molecular Diagnostics Market
        • 8.4.5.5.1 South Africa Point of Care Molecular Diagnostics Market by Product & Service
        • 8.4.5.5.2 South Africa Point of Care Molecular Diagnostics Market by End User
        • 8.4.5.5.3 South Africa Point of Care Molecular Diagnostics Market by Technology
        • 8.4.5.5.4 South Africa Point of Care Molecular Diagnostics Market by Application
      • 8.4.5.6 Nigeria Point of Care Molecular Diagnostics Market
        • 8.4.5.6.1 Nigeria Point of Care Molecular Diagnostics Market by Product & Service
        • 8.4.5.6.2 Nigeria Point of Care Molecular Diagnostics Market by End User
        • 8.4.5.6.3 Nigeria Point of Care Molecular Diagnostics Market by Technology
        • 8.4.5.6.4 Nigeria Point of Care Molecular Diagnostics Market by Application
      • 8.4.5.7 Rest of LAMEA Point of Care Molecular Diagnostics Market
        • 8.4.5.7.1 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service
        • 8.4.5.7.2 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User
        • 8.4.5.7.3 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology
        • 8.4.5.7.4 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application

Chapter 9. Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 SWOT Analysis
  • 9.2 Bayer AG
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 SWOT Analysis
  • 9.3 Thermo Fisher Scientific, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expenses
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Acquisition and Mergers:
    • 9.3.6 SWOT Analysis
  • 9.4 F. Hoffmann-La Roche Ltd.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
      • 9.4.5.2 Product Launches and Product Expansions:
      • 9.4.5.3 Acquisition and Mergers:
  • 9.5 BioMerieux S.A.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Acquisition and Mergers:
  • 9.6 Qiagen N.V.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
  • 9.7 Danaher Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expense
  • 9.8 Bio-Rad laboratories, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Acquisition and Mergers:
  • 9.9 Agilent Technologies, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Partnerships, Collaborations, and Agreements:
  • 9.10. Nova Biomedical Corporation
    • 9.10.1 Company Overview